The quality tilt is cheap to buy and hard to hold

Two advisors are positioning for 2026 with opposite theses and, in the end, much the same shelf of funds. Anna Rathbun, founder and chief executive of Grenadilla Advisory, wants client portfolios leaning toward quality and value because she sees leverage building beneath an economy that otherwise looks strong, while Jeffrey Ingraham, who heads portfolio strategy at EP Wealth Advisors, is making the other case — that this year finally rewarded the patient, diversified client. The vehicles underneath both arguments are Vanguard, Dimensional and iShares index funds, and that overlap is where a principal should start reading.

Rathbun's evidence sits outside the earnings tape, which she describes as strong; she points to headlines about borrowing tied to artificial intelligence infrastructure and to private credit deals that fall through, and treats both as early warnings worth positioning around. Her prescription is a lean rather than a wager — as risks build, she argues, it can make sense to tilt toward the quality and value factors that have historically held up better once fear enters market sentiment, without overcommitting to that outcome. She gets there through the Vanguard Quality Factor ETF for broad quality exposure and the Vanguard US Value Factor ETF for value.

Ingraham's frame is the mirror image, a year in which non-US equities and US small caps beat US large caps for the first time in a long while, as he puts it, and clients who declined to crowd into the biggest American names were paid for their patience. His small-cap sleeves run through the Vanguard Small Cap Growth ETF and the Dimensional US Targeted Value ETF; his non-US exposure runs through the iShares Core MSCI Emerging Markets ETF, which he favors for breadth across countries and market capitalizations. He also treats index classification as a live variable, noting that the line between developed and emerging can move returns materially and pointing to South Korea as this year's example.

Neither position has to be wrong, and the two are less a disagreement than a menu: one book built to survive a repricing, the other built to have already survived a long stretch of US large-cap dominance. What they share is the product answer. A quality tilt, a small-cap sleeve and an emerging-markets allocation are all available at a screen to any firm with a brokerage account, which makes the argument that gets a client to hold the ticker the differentiator, not the ticker itself.

Every tilt is funded from somewhere, and the coverage does not say what either advisor trimmed to pay for it; that omission is the first question a principal asks and the one a client letter tends to skip. A lean toward quality and value is, by construction, a lean away from whatever has been carrying the portfolio, which makes the funding source the decision and the tilt the consequence.

Duration is the harder constraint, because factor tilts are cheap to announce in a year like this one and expensive to hold in the seventh month of a tape that keeps rewarding what you sold, which is why fund selection matters less than the plan record behind it: the written rationale, the rebalancing rule, the review that tells a client the sleeve is doing its job while it underperforms. Publishing a factor tilt is the cheapest house view an RIA can hold — a handful of tickers, one memo, no new research staff — and that low cost is also why so many of them quietly expire.

Ingraham's firm is the useful test case: EP Wealth reported $45.1 billion in regulatory assets across 20,738 accounts as of September 19, roughly $2.2 million an account, behind 618 employees and 76 registered representatives. Books at that account size run on a small number of relationships that each matter, and a public argument for patience in a book like that does retention work alongside its market work.

EP Wealth is putting acquisition integration on the CFO's desk, a rollup now expecting growth to come from running partnerships rather than signing them. Integration is the stretch when clients get anxious about everything except the portfolio, and when an advisor's case for staying gets tested by service levels and platform changes rather than by returns. A portfolio strategist making the case in print that long-term discipline finally paid off is likely doing client work, whatever else the calendar says; the RIA C-suite is being rebuilt around the plan record — Edelman and Mercer filled two senior seats with product executives this week — and portfolio strategy is where that record acquires its market language.

The most loaded line in Rathbun's argument is the one about private credit deals falling through, a claim about a market the wealth industry has spent several years building a gateway into, and the gateway itself has become the M&A asset, with named vehicles and pre-sold wrappers taking the money while blind pools sit. A crack in the underlying changes what that gateway is worth. If the deals falling through are a leading signal rather than noise, the on-ramp is being completed at the moment its raw material is hardest to price, which is not the sequence a distributor would choose.

The allocation decision is easy to sell in a tape like this one, but the exit is where a gateway gets judged, and the exit is the part of the build-out that today's facts put at risk. Platforms that priced private-markets capacity on the assumption of sticky, long-hold capital will find out in the first uncomfortable quarter whether that assumption was real or promotional.

EP Wealth holds 20,738 accounts at roughly $2.2 million apiece, which is the kind of book that notices when patience stops being rewarded. Both tilts get tested in the quarter when the fear trade pays and the rest of the portfolio does not. The firm still holding its tilt that quarter will be the one whose clients saw the reasoning in writing before they needed it.